LIVER CIRCADIAN CLOCK, A PHARMACOLOGIC TARGET OF CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB

REFERENCES

• Akashi M, Tsuchiya Y, Yoshino T, Nishida E. (2002). Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells. Mol. Cell. Biol. 22:1693–1703.
   PubMed Web of Science ®Google Scholar
• Bachmeier CJ, Miller DW. (2005). A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier. Pharm. Res. 22:113–121.
   PubMedGoogle Scholar
• Bruguerolle B. (1998). Chronopharmacokinetics. Current status. Clin. Pharmacokinet. 35:83–94.
   PubMed Web of Science ®Google Scholar
• Dardente H, Cermakian N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24:195–213.
   PubMed Web of Science ®Google Scholar
• De Prins J, Hecquet B. (1992). In Touitou Y, Haus E. ( eds). Biological rhythms in clinical and laboratory medicine. Berlin: Springer Verlag, pp. 90–112.
   Google Scholar
• Eide EJ, Woolf MF, Kang H, Woolf P, Hurst W, Camacho F, Vielhaber EL, Giovanni A, Virshup DM. (2005). Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol. Cell. Biol. 25:2795–2807.
   PubMed Web of Science ®Google Scholar
• Etienne-Grimaldi MC, Cardot JM, François E, Renée N, Douillard JY, Gamelin E, Bennouna J, Château Y, Milano G. (2007). Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients. Clin. Pharmacol. Ther. 83:413–415.
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Li XM, Granda TG, Mormont MC, Liu XH, Claustrat B, Hastings MH, Lévi F. (2002). Host circadian clock as a control point in tumor progression. J. Nat. Cancer Inst. 94:690–697.
   PubMed Web of Science ®Google Scholar
• Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH, Lévi F. (2004). Effects of chronic jet lag on malignant growth in mice. Cancer Res. 64:7879–7885.
   PubMed Web of Science ®Google Scholar
• Filipski E, Innominato PF, Wu M, Li XM, Iacobelli S, Xian LJ, Lévi F. (2005). Effects of light and food schedules on liver and tumor molecular clock. J. Nat. Cancer Inst. 97:507–517.
   PubMed Web of Science ®Google Scholar
• Fu L, Lee CC. (2003). The circadian clock: Pacemaker and tumour suppressor. Nat. Rev. Cancer. 3:350–361.
   PubMed Web of Science ®Google Scholar
• Fu L, Pelicano H, Liu J, Huang P, Lee CC. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50.
   PubMed Web of Science ®Google Scholar
• Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. (2006). The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 4:25–36.
   PubMed Web of Science ®Google Scholar
• Gallego M, Virshup DM. (2007). Post-translational modifications regulate the ticking of the circadian clock. Nat. Rev. Mol. Cell Biol. 8:139–148.
   PubMed Web of Science ®Google Scholar
• Haus E. (2007). Circadian disruption in shiftwork is probably carcinogenic to humans. Chronobiol. Int. 24:1255–1256.
   PubMed Web of Science ®Google Scholar
• Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S, Genet D, Tampellini M, Chollet P, Lentz MA, Mormont MC, Lévi F, Bjarnason GA for the ARTBC Chronotherapy Group (2009). Circadian rhythm in rest and activity: A biological correlate of health-related quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res.69:4700–4707.
   PubMed Web of Science ®Google Scholar
• Iurisci I, Filipski E, Reinhardt J, Bach S, Gianella-Borradori A, Iacobelli S, Meijer L, Lévi F. (2006). Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 66:10720–10728.
   PubMed Web of Science ®Google Scholar
• Knockaert M, Greengard P, Meijer L. (2002). Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23:417–425.
   PubMed Web of Science ®Google Scholar
• Labrecque G, Sirois-Labrecque M. (2003). Chronopharmacologie. Rythmes biologiques et administration des médicaments. Canada: Les Presses de l'Univ. de Montréal, Montréal, 420pp.
   Google Scholar
• Lemmer B. (2006). The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacol. Ther. 111:629–651.
   PubMed Web of Science ®Google Scholar
• Lévi F, Schibler U. (2007). Circadian rhythms: Mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 47:593–628.
   PubMed Web of Science ®Google Scholar
• Lévi F, Filipski E, Iurisci I, Li XM, Innominato P. ( ed.). (2007). Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harbor Symposia on Quantitative Biology. Vol. LXXII. Cold Spring Harbour Laboratory Press, Woodbury, NY, pp. 1–11.
   Google Scholar
• Li XM, Lévi F. (2007). Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice. J. Biol. Rhythms. 22:159–166.
   PubMed Web of Science ®Google Scholar
• Luft JH. (1961). Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9:409–414.
   PubMedGoogle Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255–259.
   PubMed Web of Science ®Google Scholar
• McClue SJ, Stuart I. (2008). Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo. Drug Metab. Disp. 36:561–570.
   PubMed Web of Science ®Google Scholar
• Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-depedent kinases cdc2, cdk2, and cdk5. Eur. J. Biochem. 243:527–536.
   PubMedGoogle Scholar
• Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, Lévi F. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 6:3038–3045.
   PubMed Web of Science ®Google Scholar
• Ohdo S, Suyama H, Higuchi S, Aramaki H. (2001). Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat. Med. 7:356–360.
   PubMed Web of Science ®Google Scholar
• Oklejewicz M, Destici E, Tamanini F, Hut RA, Janssens R, van der Horst GT. (2008). Phase resetting of the mammalian circadian clock by DNA damage. Curr. Biol. 18:286–291.
   PubMed Web of Science ®Google Scholar
• Phelps M, Lin TS, Johnson AJ, Hurh E, Rozewski DM, Farley KL, Wu D, Blum KA, Fischer B, Mitchell SM, Moran ME, Booker-McEldowney M, Heerema NA, Jarjoura D, Schaaf LJ, Byrd JC, Grever MR, Dalton JT. (2009). Clinical response and pharmacokinetics from a phase I study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood 113:2637–2645.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky M. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
   PubMed Web of Science ®Google Scholar
• Qu X, Metz RP, Porter WW, Cassone VM, Earnest DJ. (2009). Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver. Toxicol. Appl. Pharmacol. 234:370–377.
   PubMed Web of Science ®Google Scholar
• Radzialowski FM, Bousquet WF. (1967). Daily rhythmic variation in hepatic drug metabolism in the rat and mouse. J. Pharmacol. Exp. Ther. 163:229–238.
   Google Scholar
• Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92:994–1000.
   PubMed Web of Science ®Google Scholar
• Sidbury JB, Jr, Cornblath M, Fisher J, House E. (1961). Glycogen in erythrocytes of patients with glycogen storage disease. Pediatrics 27:103–111.
   Google Scholar
• Siegel-Lakhai WS, Rodenstein DO, Beijnen JH, Gianella-Borradori A, Schellens JH, Talbot DC. (2005). Phase IIa study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC). Abstract 2060. American Society of Clinical Oncology Annual Meeting, Orlando, Florida, 13–17 May.
   Google Scholar
• Smith RD, Turek FW, Takahashi JS. (1992). Two families of phase-response curves characterize the resetting of the hamster circadian clock. Am. J. Physiol. 262(6 Pt 2):R1149–R1153.
   Google Scholar
• Smolensky M, Peppas N. (2007). Chronobiology, drug delivery and chronotherapeutics. Adv. Drug Deliv. Rev. 59:828–851.
   PubMed Web of Science ®Google Scholar
• Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Ben Brahim-Tallaa L, Cogliano V on behalf of the WHO International Agency for Research on Cancer Monograph Working Group2007). Carcinogenicity of shift work, painting and firefighting. Lancet Oncol. 8:1065–1066.
   PubMed Web of Science ®Google Scholar
• Summer TL, Ferraro JS, McCormack CE. (1984). Phase-response and Aschoff illuminance curves for locomotor activity rhythm of the rat. Am. J. Physiol. 246:R299–R304.
   PubMed Web of Science ®Google Scholar
• Terazono H, Hamdan A, Matsunaga N, Hayasake N, Kaji H, Egawa T, Makino K, Shigeyoshi Y, Koyonagi S, Ohdo S. (2008). Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes: A possible mechanism of chemotherapy-induced circadian rhythm disturbances. Biochem. Pharmacol. 75:1616–1622.
   Google Scholar
• Vita M, Meurling L, Pettersson T, Cruz-Sidén M, Sidén A, Hassan M. (2004). Analysis of roscovitine using novel high performance liquid chromatography and UV-detection method: Pharmacokinetics of roscovitine in rat. J. Pharm. Biomed. Anal. 34:425–431.
   PubMed Web of Science ®Google Scholar
• Vita M, Abdel-Rehim M, Olofsson S, Hassan Z, Meurling L, Sidén A, Sidén M, Pettersson T, Hassan M. (2005). Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat. Eur. J. Pharm. Sci. 25:91–103.
   PubMed Web of Science ®Google Scholar
• Zhang YK, Yeager RL, Klaassen CD. (2008). Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab. Dispos. 37:106–115.
   PubMedGoogle Scholar